MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Syneron Medical Company Profile (NASDAQ:ELOS)

Consensus Ratings for Syneron Medical (NASDAQ:ELOS) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $18.00 (74.42% upside)

Analysts' Ratings History for Syneron Medical (NASDAQ:ELOS)
Show:
DateFirmActionRatingPrice TargetActions
7/10/2015Brean CapitalReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015Brean CapitalReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Brean CapitalReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/8/2015Brean CapitalReiterated RatingBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/6/2015Brean CapitalSet Price TargetBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015Brean CapitalInitiated CoverageBuy$18.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/16/2014Leerink SwannLower Price Target$17.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/3/2014Leerink SwannBoost Price Target$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2013Cantor FitzgeraldReiterated RatingBuy$15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/14/2013Griffin SecuritiesBoost Price TargetBuy$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/11/2013Leerink SwannReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/13/2013Cantor FitzgeraldLower Price TargetBuy$16.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/15/2013Griffin SecuritiesLower Price TargetBuy$15.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 8/2/2013 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha